Nova IVF Buys CRAFT Hospitals for $40M to Boost Kerala Presence

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Nova IVF Buys CRAFT Hospitals for $40M to Boost Kerala Presence
Overview

Bengaluru-based Nova IVF Fertility has acquired a majority stake in Kerala's CRAFT Hospitals for approximately $40 million (₹368 crore). This strategic move fills a crucial gap in Nova IVF's South Indian presence, allowing it to tap into Kerala's substantial specialized healthcare market. The deal is underpinned by significant private equity interest in the Indian healthcare sector, particularly in Kerala, which has seen over $700 million invested in recent years. Nova IVF operates under Asia Healthcare Holdings, backed by TPG Capital.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Nova IVF Expands in South India with $40 Million CRAFT Hospitals Acquisition

Nova IVF Fertility, a prominent player in India's assisted reproductive technology sector, has acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore). This strategic move significantly expands Nova IVF's presence in South India, filling a crucial gap in its network within the state. The deal was facilitated by investment bank Advay Capital for CRAFT and its promoter, C Mohamed Ashraf.

The acquisition aligns with Nova IVF's goal to strengthen its position in the growing South Indian healthcare market. CRAFT Hospitals provides Nova IVF with immediate access to Kerala's demand for specialized medical services. Nova IVF operates under Asia Healthcare Holdings (AHH), backed by global private equity firm TPG Capital, with AHH focused on building integrated single-specialty healthcare platforms. This transaction occurs amid substantial private equity investment flowing into Kerala's healthcare sector, which has attracted over $700 million in capital recently, highlighting the region's attractiveness.

India's fertility services market is experiencing rapid expansion, projected to grow from about $1.5 billion in 2024 to over $4.4 billion by 2033. This growth is driven by increasing infertility rates, people delaying parenthood, and greater awareness of advanced IVF treatments. Nova IVF, which has previously expanded by acquiring entities like WINGS IVF, competes with major chains such as Indira IVF (valued at $1.1 billion in a recent transaction) and Apollo Fertility, as well as numerous regional providers.

Despite the promising market outlook, Nova IVF faces challenges in integrating CRAFT Hospitals into its operational framework and ensuring consistent service quality. The competitive intensity in the Indian IVF market remains high. Furthermore, healthcare M&A in India requires navigating a complex regulatory environment, including approvals, licensing, and compliance with data protection laws. Successfully integrating CRAFT and achieving sustained profitability will depend on effectively managing these operational and regulatory aspects.

Nova IVF's acquisition of CRAFT Hospitals signals a continuation of the consolidation trend in India's rapidly growing fertility services sector. The company is strategically positioning itself for further expansion in key Southern markets, aiming to capitalize on strong market growth drivers.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.